Founded Year
2008About OvaGene Oncology
OvaGene Oncology is a molecular diagnostics that provides gene-based assays to assist physicians/gynecologic oncologists in the diagnosis, radiation, and chemotherapy, prognosis, and therapy selection of gynecologic cancers in women. It offers gene-based tumor profiling tests including pharmacogenetic analysis, next-gen sequencing and tumor drug response; ovarian, uterine/endometrial, and cervical cancer assays, including chemotherapy drug response profiles, targeted therapy response profiles, next-gen sequencing for targeted therapy, and pharmacogenetic assays.
Missing: OvaGene Oncology's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: OvaGene Oncology's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
OvaGene Oncology Frequently Asked Questions (FAQ)
When was OvaGene Oncology founded?
OvaGene Oncology was founded in 2008.
Where is OvaGene Oncology's headquarters?
OvaGene Oncology's headquarters is located at 10 Pasteur Street, Irvine.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.